Any stock, in context
MANKIND · Healthcare
Mankind Pharma Ltd.
Observation · 15 Oct 2026
How these are readMankind Pharma closed at ₹2,347.6 on 15 Oct 2026, 1.8% above its 200-day average and 2.1% below its 50-day average: above the long line, below the short one. It sits 10.3% below its highest close of the past year, in the middle fifth of its one-year range. Over three months it fell 5.5%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +1.8%
- the long line
- vs 50-day
- −2.1%
- the short line
- From 52w high
- −10.3%
- ₹1,909.7₹2,642.0
- 3 months
- −5.5%
- sector median −2.7% · 84 of 146
Nifty Midcap 150 · Healthcare · EQ series · median traded value ₹83 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- +0.54%
- 1W
- –
- 1M
- +2.94%
- 3M
- −5.50%
- YTD
- –
- 1Y
- −4.01%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.